Next-level molecular intelligence to empower biotechnology.
IsoSpec Analytics SA
Incorporated
20.10.2022Headquarters
DenensSupport
Isospec Analytics SA develops and commercializes disruptive analytical technologies to enable biomarker discovery and accelerate pharmaceutical and biotech product development. The company currently provides research services in glycomics and metabolomics as a transition before commercializing analytical instruments and software tools. By combining infrared fingerprinting with machine learning, we provide our customers with the needed molecular intelligence to move forward with certainty.
News
Bio Europe in Stockholm hosts 33 Swiss companies (startupticker.ch)
Voltiris and IsoSpec Analytics get FIT Boost (startupticker.ch)
Isospec raises USD 1.9 Million to revolutionize human health through rapid diagnostics (venturelab.swiss)
Isospec Analytics raises $1.9m for its technology to identify molecules at scale (startupticker.ch)
Student VC Founderful Campus starts a new chapter (startupticker.ch)
A decent representation at BIO-Europe (startupticker.ch)
Venture Leaders Biotech 2023: Captain’s Blog by Navignostics, Mosanna Therapeutics, Limula, and Tandem Therapeutics (venturelab.swiss)
CHF 150,000 to empower biotechnologies through molecular intelligence (startupticker.ch)
The Venture Leaders Biotech set sail on the Boston roadshow with immersive expert workshops, uniting entrepreneurs and investors in the US market (venturelab.swiss)
Isospec Analytics: Meet the Venture Leader Biotech aiming to be the backbone of precision medicine (venturelab.swiss)
Startup Champions Seed Night 2023 celebrates rising stars of the Swiss startup ecosystem (venturelab.swiss)
Venture Leaders Biotech kick off their Boston roadshow at Swiss Biotech Day (venturelab.swiss)
Ten biotech startups head to Boston (startupticker.ch)
Swiss National Startup Team 2023: 10 biotech innovators are headed to Boston (venturelab.swiss)
15 startups contest to win CHF 100,000 (startupticker.ch)
